318 related articles for article (PubMed ID: 31462394)
21. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients.
Lan XP; Chen YG; Wang Z; Yuan CW; Wang GG; Lu GL; Mao SW; Jin XB; Xia QH
J Zhejiang Univ Sci B; 2015 Sep; 16(9):743-56. PubMed ID: 26365116
[TBL] [Abstract][Full Text] [Related]
22. Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: A meta-analysis.
Hu J; Hu J; Liu X; Hu C; Li M; Han W
Medicine (Baltimore); 2017 Oct; 96(42):e8310. PubMed ID: 29049237
[TBL] [Abstract][Full Text] [Related]
23. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
Wang QJ; Wang H; Pan K; Li YQ; Huang LX; Chen SP; He J; Ke ML; Zhao JJ; Li JJ; Sun JC; Liang XT; Ma HQ; Chen YB; Xia JC
Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of dendritic cell-cytokine induced killer cells combined with concurrent chemoradiotherapy on locally advanced non-small cell lung cancer.
Tian L; Wang W; Yu B; Zhang G
J BUON; 2020; 25(5):2364-2370. PubMed ID: 33277857
[TBL] [Abstract][Full Text] [Related]
25. The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials.
Xiao Z; Wang CQ; Zhou MH; Li NN; Sun YP; Wang YZ; Liu SY; Yu HS; Li CW; Zeng XT; Chen L; Yao XS; Feng JH
J Immunol Res; 2018; 2018():9081938. PubMed ID: 30648123
[TBL] [Abstract][Full Text] [Related]
26. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients.
Yang L; Ren B; Li H; Yu J; Cao S; Hao X; Ren X
Cancer Immunol Immunother; 2013 Jan; 62(1):65-73. PubMed ID: 22744010
[TBL] [Abstract][Full Text] [Related]
27. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis.
Chen R; Deng X; Wu H; Peng P; Wen B; Li F; Li F
Int Immunopharmacol; 2014 Oct; 22(2):451-64. PubMed ID: 25073120
[TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy analysis of Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with Paclitaxel-Cisplatin Chemotherapy in patients with Advanced Ovarian Cancer.
Gao Y; Hao Y; Jia Y
J BUON; 2021; 26(2):553-560. PubMed ID: 34077005
[TBL] [Abstract][Full Text] [Related]
29. Dendritic Cells Therapy with Cytokine-Induced Killer Cells and Activated Cytotoxic T Cells Attenuated Th2 Bias Immune Response.
Li C; Zhu D; Zhao Y; Guo Q; Sun W; Li L; Gao D; Zhao P
Immunol Invest; 2020 Jul; 49(5):522-534. PubMed ID: 31793363
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.
Wang Y; Lv B; Li K; Zhang A; Liu H
Drug Des Devel Ther; 2017; 11():3245-3256. PubMed ID: 29180849
[TBL] [Abstract][Full Text] [Related]
31. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
[TBL] [Abstract][Full Text] [Related]
32. Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer.
Mao Q; Li L; Zhang C; Sun Y; Liu S; Cui S
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1055-8. PubMed ID: 26051718
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials.
Xiao Z; Wang CQ; Feng JH; Zhou MH; Wang YZ; Li NN; Sun YP; Liu SY; Yao XS; Li CW; Ma B; Ding J; Chen L
Cytotherapy; 2019 Feb; 21(2):125-147. PubMed ID: 30554868
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled trial of postoperative tumor lysate-pulsed dendritic cells and cytokine-induced killer cells immunotherapy in patients with localized and locally advanced renal cell carcinoma.
Zhan HL; Gao X; Pu XY; Li W; Li ZJ; Zhou XF; Qiu JG
Chin Med J (Engl); 2012 Nov; 125(21):3771-7. PubMed ID: 23106871
[TBL] [Abstract][Full Text] [Related]
35. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
[TBL] [Abstract][Full Text] [Related]
36. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
[TBL] [Abstract][Full Text] [Related]
37. Cytokine-induced killer cell/dendritic cell-cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis.
Wang X; Tang S; Cui X; Yang J; Geng C; Chen C; Zhou N; Li Y
Medicine (Baltimore); 2018 Sep; 97(36):e12230. PubMed ID: 30200148
[TBL] [Abstract][Full Text] [Related]
38. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of relapsed or refractory non-Hodgkin's lymphoma by antigen specific dendritic cells-activated lymphocytes].
Sun Y; Chen J; Cai P; Hu YH; Zhong GC; Feng HZ; Min M; Li S; Zhang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):219-23. PubMed ID: 20137151
[TBL] [Abstract][Full Text] [Related]
40. Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis.
Li CMY; Tomita Y; Dhakal B; Li R; Li J; Drew P; Price T; Smith E; Maddern GJ; Fenix KA
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
